No takes yet. Share an insight, caveat, or question.
Systematic review and meta-analysis reveals lower cancer incidence with metformin use in diabetic patients, suggesting potential chemopreventive benefits.
DeCensi et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: